Tower Research Capital LLC (Trc) Renovo Rx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 817 shares of RNXT stock, worth $841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
817
Previous 4,070
79.93%
Holding current value
$841
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RNXT
# of Institutions
21Shares Held
2MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1 Million0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA236KShares$242,8200.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX197KShares$203,1670.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA141KShares$145,7310.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$100,0790.01% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.34M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...